December 2 Update - FAQs on Testing for SARS-CoV-2

FDA has updated Info on Testing for SARS-CoV-2

If your email program has trouble displaying this email, view as a webpage. December 2 Update: Updated Information on Testing for SARS-CoV-2  Thank you for your interest in the development of diagnostics for SARS-CoV-2.  The FDA recently UPDATED the answer to the following questions: Serology/Antibody Tests If antibody tests are not used for diagnosis or exclusionof COVID-19 infection, what is their purpose? COVID-19 Testing Supplies I am considering offering clinical testing using the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel. What are the considerations I should be aware of regarding extraction platforms ? FAQs on Testing for SARS-CoV-2 Questions? Email CDRH-EUA-Templates@fda.hhs.gov

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA